Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
BRK.B -3.34ATD.TO -1.95COST -4.36CPX.TO -0.16LNR.TO -0.41STM -1.86MSCI 2.5V 1.29
Daily Stock Opinions and Ratings
Stockchase Opinions

Jenny Harrington, CEO, Gilman Hill Asset ManagementOrganonOGNBUYJul 14, 2023

Spun off from Merck two years, but has been sitting in the penalty box. Pays a 5.5% dividend at 5x earnings. 

Jenny Harrington, CEO, Gilman Hill Asset ManagementJenny Harrington, CEO, Gilman Hill Asset Management
Unknown
Unlock Rating
$20.59

Stock price when the opinion was issued

$13.73

As of Aug 19, 2026. Market Open.

Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Organon(OGN)

Dec 01, 2023

Recently on a downward trend. Fundamentally scores 3/10. Would not recommend buying. Price target falling. Has not been able to beat earnings. Better options available for investors. High debt levels not good for dividend outlook. 

Photo of Brianne GardnerBrianne GardnerUnlock Rating
$11.50

Stock price when the opinion was issued

$13.73

As of Aug 19, 2026. Market Open.

Pharma & Healthcare
DON'T BUY

Organon(OGN)

May 22, 2023

It has no growth.

Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
$20.85

Stock price when the opinion was issued

$13.73

As of Aug 19, 2026. Market Open.

Pharma & Healthcare

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

BKNG 4.75$213
NFLX 2.45$80.22
MSCI 2.5$565.27
MSFT 2.68$484.31
TOU.TO 0.55$61.27

Today's Top Picks

BRK.B -3.34$499.62
ATD.TO -1.95$87.98
COST -4.36$956.99
CPX.TO -0.16$66.35
LNR.TO -0.41$105

Popular Articles

Latest Sell Signals

PBH.TO 1.16$81.25
APTX.TO 0$
SLF.TO -2.03$109.92
TRP.TO -2.87$86.15
CCA.TO -0.29$60.88

Most Recent Experts

Barry Schwartz

Barry Schwartz

Baskin Wealth Management

Jamie Murray

Jamie Murray

Murray Wealth Group

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automatically